IL115100A - Stereoselective process for producing 5-aryl-8,9-dihydro-7H-1,3-dioxolo¬4,5-h¾-2,3-benzodiazepine derivatives and the intermediate 5-aroyl-6-(2-substituted alkyl)-1,3-benzodioxole hydrazone derivatives therefor - Google Patents

Stereoselective process for producing 5-aryl-8,9-dihydro-7H-1,3-dioxolo¬4,5-h¾-2,3-benzodiazepine derivatives and the intermediate 5-aroyl-6-(2-substituted alkyl)-1,3-benzodioxole hydrazone derivatives therefor

Info

Publication number
IL115100A
IL115100A IL11510095A IL11510095A IL115100A IL 115100 A IL115100 A IL 115100A IL 11510095 A IL11510095 A IL 11510095A IL 11510095 A IL11510095 A IL 11510095A IL 115100 A IL115100 A IL 115100A
Authority
IL
Israel
Prior art keywords
derivatives
dihydro
dioxolo
benzodioxole
aroyl
Prior art date
Application number
IL11510095A
Other languages
English (en)
Other versions
IL115100A0 (en
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/413,036 external-priority patent/US5665878A/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL115100A0 publication Critical patent/IL115100A0/xx
Publication of IL115100A publication Critical patent/IL115100A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL11510095A 1994-08-31 1995-08-30 Stereoselective process for producing 5-aryl-8,9-dihydro-7H-1,3-dioxolo¬4,5-h¾-2,3-benzodiazepine derivatives and the intermediate 5-aroyl-6-(2-substituted alkyl)-1,3-benzodioxole hydrazone derivatives therefor IL115100A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29864594A 1994-08-31 1994-08-31
US08/413,036 US5665878A (en) 1994-08-31 1995-03-28 Stereoselective process for producing dihydro-2,3-benzodiazepine derivatives

Publications (2)

Publication Number Publication Date
IL115100A0 IL115100A0 (en) 1995-12-08
IL115100A true IL115100A (en) 2000-07-26

Family

ID=26970799

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11510095A IL115100A (en) 1994-08-31 1995-08-30 Stereoselective process for producing 5-aryl-8,9-dihydro-7H-1,3-dioxolo¬4,5-h¾-2,3-benzodiazepine derivatives and the intermediate 5-aroyl-6-(2-substituted alkyl)-1,3-benzodioxole hydrazone derivatives therefor

Country Status (21)

Country Link
US (3) US5919954A (it)
EP (1) EP0699677B1 (it)
JP (1) JP3481019B2 (it)
KR (1) KR100399518B1 (it)
CN (1) CN1086705C (it)
AT (1) ATE231867T1 (it)
AU (1) AU702658B2 (it)
BR (1) BR9503845A (it)
CA (1) CA2157234C (it)
CZ (1) CZ295675B6 (it)
DE (1) DE69529499T2 (it)
DK (1) DK0699677T3 (it)
ES (1) ES2189819T3 (it)
FI (1) FI113269B (it)
HU (1) HU223776B1 (it)
IL (1) IL115100A (it)
IN (1) IN190402B (it)
NO (1) NO312838B1 (it)
PL (3) PL188796B1 (it)
RU (1) RU2151149C1 (it)
TR (1) TR199501071A2 (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010022856A (ko) * 1997-08-12 2001-03-26 사바 키스 ; 아틸라 만디 야노스 템페 ; 기울라 시미그 Ａｍｐａ/카이네이트 수용체 억제제로서의 1,3-디옥솔로/4,5-ｈ//2,3/벤조디아제핀 유도체
UA67749C2 (uk) * 1997-08-12 2004-07-15 Егіш Дьйодьсердьяр Рт. Похідна 8-заміщеного-9н-1,3-діоксол/4,5-h//2,3/бензодіазепіну з властивостями амра/каїнатного антагоніста, спосіб одержання похідних, фармацевтична композиція (варіанти), спосіб її одержання та спосіб лікування
EP0918090A3 (en) * 1997-11-04 2002-08-28 Eli Lilly And Company Ketoreductase gene and protein from yeast
US20030219456A1 (en) * 2002-05-21 2003-11-27 Taing Ok Method of utilization of zygosaccharomyces rouxii
US6858605B2 (en) 2003-02-04 2005-02-22 Ivax Drug Research Institute, Ltd. Substituted 2,3-benzodiazepine derivatives
DE502005006892D1 (de) * 2005-12-05 2009-04-30 Deutsche Post Ag Verfahren zum Sortieren von Postsendungen und Vorrichtung mit einer Datenstruktur für einen Sortierplan
AU2006334172A1 (en) * 2005-12-30 2007-07-12 Egis Gyogyszergyar Nyilvanosan Mukodo Reszvenytarsasag Optical isomers of dihydro-2,3-benzodiazepines and their stereoselective synthesis
KR100841592B1 (ko) 2007-04-16 2008-06-26 한양대학교 산학협력단 벤조디옥솔 유도체와 이의 제조방법

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3748342A (en) * 1971-05-06 1973-07-24 Sandoz Ag Intermediates for preparing quinazolinones
US3794642A (en) * 1973-01-15 1974-02-26 Lilly Co Eli Oxidation of substituted methanes to the corresponding substituted methanols
DE2816475A1 (de) * 1978-04-15 1979-10-25 Bayer Ag Isochroman-derivate, verfahren zu ihrer herstellung und ihre verwendung als synergisten in insektiziden und akariziden mitteln
US4358041A (en) 1980-06-12 1982-11-09 Olin Corporation Powder-actuated tool with power adjustment and angle-fire control
HU191702B (en) * 1984-06-27 1987-03-30 Gyogyszerkutato Intezet New process for preparing 1-aryl-5 h-2,3-benzodiazepines
HU191698B (en) * 1984-07-27 1987-03-30 Gyogyszerkutato Intezet Process for producing new 1-aryl-5h-2beta-benzodiazepines
HU198494B (en) 1986-08-15 1989-10-30 Gyogyszerkutato Intezet Process for producing new 3,4-dihydro-5h-2,3-benzodiazepine derivative and acid addition salts thereof, as well as pharmaceutical compositions comprising same
DE68926417T2 (de) * 1988-02-12 1996-09-12 Daicel Chem Verfahren zur herstellung von optisch aktiven 2-hydroxysäureabkömmlingen
JP2679145B2 (ja) * 1988-09-02 1997-11-19 ダイセル化学工業株式会社 オキシケトンの製造法
HU219778B (hu) * 1990-12-21 2001-07-30 Gyógyszerkutató Intézet Közös Vállalat Eljárás N-acil-2,3-benzodiazepin-származékok, savaddíciós sóik és az ezeket tartalmazó gyógyászati készítmények előállítására, valamint a vegyületek egy csoportja, és az ezeket tartalmazó gyógyászati készítmények
HU206719B (en) 1990-12-21 1992-12-28 Gyogyszerkutato Intezet Process for producing 1-/4-acylamino-phenyl/-7,8-methylenedioxy-5h-2,3-benzodiazepine derivatives, acid addicional salts and pharmaceutical compositions containing them
JP3061422B2 (ja) * 1990-12-27 2000-07-10 ダイセル化学工業株式会社 光学活性（ｓ）−２−クロロ−１−フェニルプロパノールの製造法
JPH04271789A (ja) * 1991-01-10 1992-09-28 Takeda Chem Ind Ltd Ｄ−パントラクトンの製造方法
HU219777B (hu) * 1993-07-02 2001-07-30 Gyógyszerkutató Intézet Kft. Optikailag aktív 1-(4-nitro-fenil)-4-metil-7,8-metiléndioxi-3,4-dihidro-5H-2,3-benzodiazepin és eljárás előállítására

Also Published As

Publication number Publication date
US6160133A (en) 2000-12-12
US5919954A (en) 1999-07-06
US5986114A (en) 1999-11-16
DE69529499D1 (de) 2003-03-06
IN190402B (it) 2003-07-26
JP3481019B2 (ja) 2003-12-22
HK1013818A1 (en) 1999-09-10
IL115100A0 (en) 1995-12-08
CA2157234A1 (en) 1996-03-01
AU3035595A (en) 1996-03-14
PL188796B1 (pl) 2005-04-29
TR199501071A2 (tr) 1996-06-21
PL310226A1 (en) 1996-03-04
FI954064A0 (fi) 1995-08-30
NO312838B1 (no) 2002-07-08
DK0699677T3 (da) 2003-04-22
ES2189819T3 (es) 2003-07-16
CN1086705C (zh) 2002-06-26
HU9502545D0 (en) 1995-10-30
FI113269B (fi) 2004-03-31
CZ295675B6 (cs) 2005-09-14
NO953396D0 (no) 1995-08-30
KR100399518B1 (ko) 2004-04-30
RU2151149C1 (ru) 2000-06-20
HUT72644A (en) 1996-05-28
KR960007595A (ko) 1996-03-22
PL190318B1 (pl) 2005-11-30
EP0699677A1 (en) 1996-03-06
ATE231867T1 (de) 2003-02-15
CN1123282A (zh) 1996-05-29
NO953396L (no) 1996-03-01
HU223776B1 (hu) 2005-01-28
CA2157234C (en) 2005-05-03
JPH0881468A (ja) 1996-03-26
BR9503845A (pt) 1996-04-16
DE69529499T2 (de) 2003-12-04
FI954064L (fi) 1996-03-01
EP0699677B1 (en) 2003-01-29
PL190640B1 (pl) 2005-12-30
AU702658B2 (en) 1999-02-25
CZ221995A3 (en) 1996-03-13

Similar Documents

Publication Publication Date Title
BG105781A (en) Piperidine, tetrahydropyridine and piperazine derivatives, their preparartion and use
IL148157A0 (en) Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
HU9601857D0 (en) New benzyl-piperidine- or -tetrahydro-pyridine derivatives and processes for producing them
IL134905A0 (en) Novel intermediates for endothelin antagonistic pyrrolidine derivatives
HUT64941A (en) New method for producing 7-(substituted)-9-[(substituted glycyl)-amido]-6-desmethyl-6-desoxy-tetracyclines
PL293316A1 (en) Method of obtaining quinozolinone derivatives
HUT70513A (en) Piperazine derivatives as 5-ht receptors antagonists, pharmaceutical compositions comprising them and method for producing thereof
AU6422198A (en) {1,2,4}triazolo{1,5-c}pyrimidine derivatives
HU913792D0 (en) Method for producing serotonine antagonists
AU3015289A (en) 2'-deoxy-5-fluorouridine derivatives
PL287631A1 (en) Method of obtaining novel substituted derivatives of n-/imidazolil/-alkyl-alamine
AU2977897A (en) Amide derivatives
HU902129D0 (en) Process for producing tetrahydrobenzo-(c,d)-indole derivatives
CA2281918A1 (en) Oxazolidines as 5-ht2a-antagonists
HU9502545D0 (en) Stereoselective process for producing dihydro-2,3-benzodiazepine derivatives
MY117754A (en) Stereoselective process for producing dihydro-2, 3-benzodiazepine derivatives
ATE234828T1 (de) Hydronaphtho(2,3-c)furan-derivate und verfahren zu ihrer herstellung
IE880306L (en) Pyridopyrroloquinolines and intermediates thereof
BG105247A (en) N-substituted azabicycloheptane derivatives, production and use thereof
EP0413832A4 (en) Oxazolidinedione derivatives and production thereof
EP0798304A4 (en) DRUGS AGAINST TRHOMBOCYTOPENIA
GR3019559T3 (en) 4-[4- or 6-(Trifluoromethyl-2-pyridinyl)]-1-piperazinyl-alkyl substituted lactams
TW430666B (en) New 5H-thiazolo[3,2-a]pyrimidin-5-one derivatives
AU6496790A (en) New 1,3,4-trisubstituted 2-azetidinone derivatives, useful as intermediates for the synthesis of beta-lactams, and process for their asymmetric synthesis

Legal Events

Date Code Title Description
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees